Aptar Group said its intranasal medical delivery technology will be used to administer Cardamyst, a treatment for paroxysmal supraventricular tachycardia in adults.
The recall of nasal sprays has been expanded. MediNatura New Mexico Inc. already recalled all lots of ReBoost Nasal Spray ...
Additional nasal sprays are being recalled, federal health officials say, expanding a nationwide recall issued last week.
The FDA issued an expanded recall of ReBoost Nasal Spray and ClearLife Allergy Nasal Spray sold by MediNatura New Mexico ...
The company said there is “reasonable probability” that customers who are immunocompromised could have health complications including life-threatening infections if they use the products.
“Duke Dining didn’t just answer our questions – they embraced us,” Seth Lee said. “They made Jacob feel seen, safe, and ...
Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.
The ReBoost Nasal Spray may contain mold and microbial contamination, while the ClearLife Allergy Nasal Spray may be linked ...
Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.
Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...
Publix posted Monday that its stores are included in last week's recall of ReBoost Nasal Spra y, which "has been found to ...